OSBPL2-mediated lipid metabolism alteration governs lung cancer stem cells properties

Lung cancer is the first leading cause of cancer death worldwide. oxysterol-binding protein-like 2 (OSBPL2), is a lipid transport protein regulating cholesterol homeostasis. Here, we clarified the previously unreported role of OSBPL2 in lung cancer stemness properties. We observed that OSBPL2 reduced cholesterol content by HPLC-MS. It inhibited the accumulation of lipid droplets (LDs) in lung cancer. OSBPL2-mediated lipid transportation significantly suppressed tumor sphere formation, stemness markers expression and in vivo tumorigenesis and tumor metastasis. In clinical specimens, we also demonstrated that OSBPL2 repressed the expression of Lung cancer stem-like cells (LCSCs) markers-ALDH1A1, CD133 and Nanog. The level of OSBPL2 was negatively correlated with malignant of lung cancer, such as tumor stage progression and lymph node metastasis. Taken together, these findings illustrated that OSBPL2-mediated lipid transportation inhibited the stemness and aggressiveness of lung cancer cells. OSBPL2 was a potential therapeutic target to develop novel cancer-preventive compound.

Authors

Institutions

Publication Details

Journal
Stem Cell Research & Therapy
Published
2026-02-05
DOI
https://doi.org/10.1186/s13287-026-04919-4
Primary Topic
Cancer, Lipids, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

OSBPL2-mediated lipid metabolism alteration governs lung cancer stem cells properties

Guangliang Bian, Yue Wang, Caihua Xu, Hongtao Liu et al.
Stem Cell Research & Therapy
Cancer, Lipids, and Metabolism
article

OSBPL2-mediated lipid metabolism alteration governs lung cancer stem cells properties

Guangliang Bian, Yue Wang, Caihua Xu, Hongtao Liu, Pei Yin
article en

Abstract

Lung cancer is the first leading cause of cancer death worldwide. oxysterol-binding protein-like 2 (OSBPL2), is a lipid transport protein regulating cholesterol homeostasis. Here, we clarified the previously unreported role of OSBPL2 in lung cancer stemness properties. We observed that OSBPL2 reduced cholesterol content by HPLC-MS. It inhibited the accumulation of lipid droplets (LDs) in lung cancer. OSBPL2-mediated lipid transportation significantly suppressed tumor sphere formation, stemness markers expression and in vivo tumorigenesis and tumor metastasis. In clinical specimens, we also demonstrated that OSBPL2 repressed the expression of Lung cancer stem-like cells (LCSCs) markers-ALDH1A1, CD133 and Nanog. The level of OSBPL2 was negatively correlated with malignant of lung cancer, such as tumor stage progression and lymph node metastasis. Taken together, these findings illustrated that OSBPL2-mediated lipid transportation inhibited the stemness and aggressiveness of lung cancer cells. OSBPL2 was a potential therapeutic target to develop novel cancer-preventive compound.

Stem Cell Research & TherapyVol. 17(1)
Jiangnan University (CN), Shanghai Jiao Tong University (CN), Nantong University (CN), XinHua Hospital (CN), Soochow University (CN), Wuxi Fourth People's Hospital (CN), The Affiliated Taizhou People's Hospital of Nanjing Medical University (CN), Shanghai University of Medicine and Health Sciences (CN), First Affiliated Hospital of Soochow University (CN), Wuxi People's Hospital (CN)
Good health and well-being
Openalex Percentile: Top 67%
Cancer, Lipids, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.